Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab
Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page
- Check6 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page metadata. This change does not modify the study information or user-facing content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This reflects a new version of the page content and its metadata.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe revision on the page updated from v3.6.0 to v3.6.3, representing a minor update to the page version without altering core study details.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now shows that no participants are being recruited, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision note to reflect a page update.SummaryDifference0.3%

- Check70 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5, indicating a backend/page-system update. This does not modify the study data or visible content.SummaryDifference0.0%

- Check92 days agoChange DetectedThe study location list was updated to add Taebuk, South Korea (28644) and remove Jungbuk, South Korea (28644); the page revision was updated from v3.5.3 to v3.5.4.SummaryDifference0.4%

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab
Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.